Comments on the d-wave pairing mechanism for cuprate high TcT_c superconductors: Higher is different?

The question of pairing glue for the cuprate superconductors (SC)is revisited and its determination through the angle resolved photo-emission spectroscopy (ARPES) is discussed in detail. There are two schools of thoughts about the pairing glue question: One argues that superconductivity in the cuprates emerges out of doping the spin singlet resonating valence bond (RVB) state. Since singlet pairs are already formed in the RVB state there is no need for additional boson glue to pair the electrons. The other instead suggests that the d-wave pairs are mediated by the collective bosons like the conventional low $T_c$ SC with the alteration that the phonons are replaced by another kind of bosons ranging from the antiferromagnetic (AF) to loop current fluctuations. An approach to resolve this dispute is to determine the frequency and momentum dependences of the diagonal and off-diagonal self-energies directly from experiments like the McMillan-Rowell procedure for the conventional SC. In that a simple d-wave BCS theory describes superconducting properties of the cuprates well, the Eliashberg analysis of well designed high resolution experimental data will yield the crucial frequency and momentum dependences of the self-energies. This line of approach using ARPES are discussed in more detail in this review, and some remaining problems are commented.Comment: Invited review article published in the Journal of Korean Physical Society; several typos corrected and a few comments and references adde

Produksi Panel Dinding Bangunan Tahan Gempa Dan Ramah Lingkungan Dari Limbah Bahan Berbahaya Dan Beracun Industri Minyak Dan Gas

Berdasarkan hasil uji karakteristik fisik terhadap panel dinding dari komposit limbah industry migas berupa activated alumina, sandblasting dan glasswall yang telah dilakukan pada tahun pertama diketahui bahwa kuat lentur tertinggi diperoleh dari sampel B4 yaitu sebesar 67,8 Kg/Cm2 dengan standar DIN 1101 17 Kg/cm2, kuat desak sampel B 2 68,31 N/mm2 dengan standar bata merah 25 N/mm2 dan batako 20 N/mm2 dan tingkat keausan terendah diperoleh dari sampel 37 streap. Dari hasil tersebut diketahui bahwa uji telah memiliki kemampuan lebih tinggi jika dibandingkan dengan standar yang berlaku. Maka pada penelitian lanjutan yang akan dilakukan bertujuan untuk mempelajari apakah produk panel dinding ini ramah lingkungan sehingga aman bagi kesehatan manusia dan lingkungan sekitarnya.Penelitian dilakukan dengan menggunakan metode uji toxicity characteristic leaching procedure (TCLP) dan LC50 terhadap produk panel dinding terbaik. Uji TCLP yang akan dilakukan yaitu dengan cara mendestruksi dan ekstraksi produk panel dinding dengan menggunakan rotating agitator selama 24 jam kemudian diuji dengan menggunakan AAS untuk mengetahui konsentrasi logam berat yang terdapat dalam produl panel dinding. Adapun untuk uji LC50 dilakukan dengan menggunakan hewan uji larva udang atau tikus.Berdasarkan hasil uji TCLP dan LC50 diketahui bahwa: a) Kadar kandungan logam berat yang terdapat di dalam wall panel setelah dilakukan uji TCLP ternyata berada dibawah baku mutu seperti yang telah ditetapkan dalam PP No.85 Tahun 1999. Jadi ini artinya produk wall panel dalam penelitian ini ramah lingkungan, b) pengujian terhadap bahan baku wall panel, Limbah Activated Alumina, Sandblasting dan Glasswoll sebelum di solidifikasi dapat mematikan sebesar 50% hewan uji pada konsentrasi 116.667 ppm dalam waktu 96 jam, dan c) hasil uji LC50 terhadap produk wall panel selama 96 jam tidak menunjukkan adanya kematian hewan uji. Dari hasil penelitian ini dapat disimpulkan bahwa produk wall panel dari limbah PT Pertamina aman bagi lingkungan dan hewan sehingga dapat dipergunakan secara publik

Critical Dynamics of a Vortex Loop Model for the Superconducting Transition

We calculate analytically the dynamic critical exponent $z_{MC}$ measured in Monte Carlo simulations for a vortex loop model of the superconducting transition, and account for the simulation results. In the weak screening limit, where magnetic fluctuations are neglected, the dynamic exponent is found to be $z_{MC} = 3/2$. In the perfect screening limit, $z_{MC} = 5/2$. We relate $z_{MC}$ to the actual value of $z$ observable in experiments and find that $z \sim 2$, consistent with some experimental results

Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent type

Aim To investigate the putative modifying effect of dual antiplatelet therapy (DAPT) use on the incidence of stent thrombosis at 3 years in patients randomized to Endeavor zotarolimus-eluting stent (E-ZES) or Cypher sirolimus-eluting stent (C-SES). Methods and results Of 8709 patients in PROTECT, 4357 were randomized to E-ZES and 4352 to C-SES. Aspirin was to be given indefinitely, and clopidogrel/ticlopidine for ≥3 months or up to 12 months after implantation. Main outcome measures were definite or probable stent thrombosis at 3 years. Multivariable Cox regression analysis was applied, with stent type, DAPT, and their interaction as the main outcome determinants. Dual antiplatelet therapy adherence remained the same in the E-ZES and C-SES groups (79.6% at 1 year, 32.8% at 2 years, and 21.6% at 3 years). We observed a statistically significant (P = 0.0052) heterogeneity in treatment effect of stent type in relation to DAPT. In the absence of DAPT, stent thrombosis was lower with E-ZES vs. C-SES (adjusted hazard ratio 0.38, 95% confidence interval 0.19, 0.75; P = 0.0056). In the presence of DAPT, no difference was found (1.18; 0.79, 1.77; P = 0.43). Conclusion A strong interaction was observed between drug-eluting stent type and DAPT use, most likely prompted by the vascular healing response induced by the implanted DES system. These results suggest that the incidence of stent thrombosis in DES trials should not be evaluated independently of DAPT use, and the optimal duration of DAPT will likely depend upon stent type (Clinicaltrials.gov number NCT00476957

EMPOWERED trial: protocol for a randomised control trial of digitally supported, highly personalised and measurement-based care to improve functional outcomes in young people with mood disorders

Objectives Many adolescents and young adults with emerging mood disorders do not achieve substantial improvements in education, employment, or social function after receiving standard youth mental health care. We have developed a new model of care referred to as 'highly personalised and measurement-based care' (HP&MBC). HP&MBC involves repeated assessment of multidimensional domains of morbidity to enable continuous and personalised clinical decision-making. Although measurement-based care is common in medical disease management, it is not a standard practice in mental health. This clinical effectiveness trial tests whether HP&MBC, supported by continuous digital feedback, delivers better functional improvements than standard care and digital support. Method and analysis This controlled implementation trial is a PROBE study (Prospective, Randomised, Open, Blinded End-point) that comprises a multisite 24-month, assessor-blinded, follow-up study of 1500 individuals aged 15-25 years who present for mental health treatment. Eligible participants will be individually randomised (1:1) to 12 months of HP&MBC or standardised clinical care. The primary outcome measure is social and occupational functioning 12 months after trial entry, assessed by the Social and Occupational Functioning Assessment Scale. Clinical and social outcomes for all participants will be monitored for a further 12 months after cessation of active care. Ethics and dissemination This clinical trial has been reviewed and approved by the Human Research Ethics Committee of the Sydney Local Health District (HREC Approval Number: X22-0042 & 2022/ETH00725, Protocol ID: BMC-YMH-003-2018, protocol version: V.3, 03/08/2022). Research findings will be disseminated through peer-reviewed journals, presentations at scientific conferences, and to user and advocacy groups. Participant data will be deidentified. Trial registration number ACTRN12622000882729

The cosmological constant: A lesson from the effective gravity of topological Weyl media

Topological matter with Weyl points, such as superfluid 3He-A, provide an explicit example where there is a direct connection between the properly determined vacuum energy and the cosmological constant of the effective gravity emerging in condensed matter. This is in contrast to the acoustic gravity emerging in Bose-Einstein condensates, where the "value of this constant cannot be easily predicted by just looking at the ground state energy of the microscopic system from which spacetime and its dynamics should emerge" (S. Finazzi, S. Liberati and L. Sindoni, The cosmological constant: a lesson from Bose-Einstein condensates, Phys. Rev. Lett. 108, 071101 (2012)). The advantage of topological matter is that the relativistic fermions and gauge bosons emerging near the Weyl point obey the same effective metric and thus the effective gravity is more closely related to real gravity. We study this connection in the bi-metric gravity emerging in 3He-A, and its relation to the graviton masses, by comparison with a fully relativistic bi-metric theory of gravity. This shows that the parameter \lambda, which in 3He-A is the bi-metric generalization of the cosmological constant, coincides with the difference in the proper energy of the vacuum in two states (the nonequilibrium state without gravity and the equilibrium state in which gravity emerges) and is on the order of the characteristic Planck energy scale of the system. Although the cosmological constant \lambda\ is huge, the cosmological term itself is naturally non-constant and vanishes in the equilibrium vacuum, as dictated by thermodynamics. This suggests that the equilibrium state of any system including the final state of the Universe is not gravitating.Comment: 7 pages, no figure

The overlapping burden of the three leading causes of disability and death in sub-Saharan African children

Despite substantial declines since 2000, lower respiratory infections (LRIs), diarrhoeal diseases, and malaria remain among the leading causes of nonfatal and fatal disease burden for children under 5 years of age (under 5), primarily in sub-Saharan Africa (SSA). The spatial burden of each of these diseases has been estimated subnationally across SSA, yet no prior analyses have examined the pattern of their combined burden. Here we synthesise subnational estimates of the burden of LRIs, diarrhoea, and malaria in children under-5 from 2000 to 2017 for 43 sub-Saharan countries. Some units faced a relatively equal burden from each of the three diseases, while others had one or two dominant sources of unit-level burden, with no consistent pattern geographically across the entire subcontinent. Using a subnational counterfactual analysis, we show that nearly 300 million DALYs could have been averted since 2000 by raising all units to their national average. Our findings are directly relevant for decision-makers in determining which and targeting where the most appropriate interventions are for increasing child survival

Mapping inequalities in exclusive breastfeeding in low- and middle-income countries, 2000–2018

Abstract: Exclusive breastfeeding (EBF)—giving infants only breast-milk for the first 6 months of life—is a component of optimal breastfeeding practices effective in preventing child morbidity and mortality. EBF practices are known to vary by population and comparable subnational estimates of prevalence and progress across low- and middle-income countries (LMICs) are required for planning policy and interventions. Here we present a geospatial analysis of EBF prevalence estimates from 2000 to 2018 across 94 LMICs mapped to policy-relevant administrative units (for example, districts), quantify subnational inequalities and their changes over time, and estimate probabilities of meeting the World Health Organization’s Global Nutrition Target (WHO GNT) of ≥70% EBF prevalence by 2030. While six LMICs are projected to meet the WHO GNT of ≥70% EBF prevalence at a national scale, only three are predicted to meet the target in all their district-level units by 2030

Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018

Anemia is a globally widespread condition in women and is associated with reduced economic productivity and increased mortality worldwide. Here we map annual 2000–2018 geospatial estimates of anemia prevalence in women of reproductive age (15–49 years) across 82 low- and middle-income countries (LMICs), stratify anemia by severity and aggregate results to policy-relevant administrative and national levels. Additionally, we provide subnational disparity analyses to provide a comprehensive overview of anemia prevalence inequalities within these countries and predict progress toward the World Health Organization’s Global Nutrition Target (WHO GNT) to reduce anemia by half by 2030. Our results demonstrate widespread moderate improvements in overall anemia prevalence but identify only three LMICs with a high probability of achieving the WHO GNT by 2030 at a national scale, and no LMIC is expected to achieve the target in all their subnational administrative units. Our maps show where large within-country disparities occur, as well as areas likely to fall short of the WHO GNT, offering precision public health tools so that adequate resource allocation and subsequent interventions can be targeted to the most vulnerable populations